Lymphotoxin expression in human and murine renal allografts

PLoS One. 2018 Jan 4;13(1):e0189396. doi: 10.1371/journal.pone.0189396. eCollection 2018.

Abstract

The kidney is the most frequently transplanted solid organ. Recruitment of inflammatory cells, ranging from diffuse to nodular accumulations with defined microarchitecture, is a hallmark of acute and chronic renal allograft injury. Lymphotoxins (LTs) mediate the communication of lymphocytes and stromal cells and play a pivotal role in chronic inflammation and formation of lymphoid tissue. The aim of this study was to assess the expression of members of the LT system in acute rejection (AR) and chronic renal allograft injury such as transplant glomerulopathy (TG) and interstitial fibrosis/tubular atrophy (IFTA). We investigated differentially regulated components in transcriptomes of human renal allograft biopsies. By microarray analysis, we found the upregulation of LTβ, LIGHT, HVEM and TNF receptors 1 and 2 in AR and IFTA in human renal allograft biopsies. In addition, there was clear evidence for the activation of the NFκB pathway, most likely a consequence of LTβ receptor stimulation. In human renal allograft biopsies with transplant glomerulopathy (TG) two distinct transcriptional patterns of LT activation were revealed. By quantitative RT-PCR robust upregulation of LTα, LTβ and LIGHT was shown in biopsies with borderline lesions and AR. Immunohistochemistry revealed expression of LTβ in tubular epithelial cells and inflammatory infiltrates in transplant biopsies with AR and IFTA. Finally, activation of LT signaling was reproduced in a murine model of renal transplantation with AR. In summary, our results indicate a potential role of the LT system in acute renal allograft rejection and chronic transplant injury. Activation of the LT system in allograft rejection in rodents indicates a species independent mechanism. The functional role of the LT system in acute renal allograft rejection and chronic injury remains to be determined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biopsy
  • DNA, Complementary / genetics
  • Graft Rejection
  • Humans
  • Kidney / metabolism*
  • Kidney Glomerulus / pathology
  • Kidney Transplantation* / adverse effects
  • Lymphotoxin-alpha / metabolism*
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transplantation, Homologous

Substances

  • DNA, Complementary
  • Lymphotoxin-alpha
  • RNA, Messenger

Grants and funding

H.S. was supported by a grant of the Hartmann-Müller Stiftung Zürich (http://www.hartmannmuellerstiftung.ch/home/); S.S. was supported by a grant of the Else Kröner-Fresenius Stiftung (https://www.ekfs.de/), the CKM-Stiftung, and a grant by Fundação Pesquisa e Disenvolvimento Humanitario. The funders had no role in study design, data collection, analysis, interpretation, decision to publish, or preparation of the manuscript.